Home MarketSun Pharma Advanced Research Company Ltd.

Sun Pharma Advanced Research Company Ltd. Stock Info: As on 2017-09-22 15:59:56

Nse

376.95

-17.40(-4.41%)
Change%
52 Week Range
272.00
30.00
431.00
23.00
Open391.05
Day's Range315.48 - 473.22
Value Traded (in ₹ Cr.) 14.03

Bse

378.35

-16.15(-4.09%)
Change %
52 Week Range
273.00
29.00
431.00
23.00
Open390.30
Day's Range315.60 - 473.40
Value Traded (in ₹ Cr.) 3.19

Stock Exchange

Category No. Of Shares Share %
ForeignPromoters 0.00 0.00%
IndianPromoters 165,255,715.00 66.93%
Mutual Funds/UTI 3,389,400.00 1.37%
FII 18,463,790.00 7.48%
Employee 0.00 0.00%
Public 35,205,110.00 14.26%
Government 0.00 0.00%
Others 23,982,605.00 9.71%
More

Key Statistics

Valuation Measures
Market Cap / Sales Ratio 42.26
Basic EPS (Rs.) -2.96
Cash EPS -2.64
BVPerShare Excl 1.26
Operating Revenue 6.81
PBDITPerShare -2.55
Dividend 0.00
NPPerShare -2.96
Current Ratio 0.53
Quick Ratio 0.53
PriceToBV 227.93
Earnings -0.01
PBDIT Margin -37.36
PBT Margin -43.39
NP Margin -43.39
Return On Assets -43.02
Retention Ratios 0.00
Parameter Mar-16 (₹ Cr.) Yoy%change
Total Income 164.22
Total Expenses 234.21
EBITDA -60.26
PBT -69.99
PAT -69.99
Net Income -69.99
More
Parameter Mar-16 (₹ Cr.) 6M % change
Total Income 77.59
Total Expenses 126.24
EBITDA -52.52
PBT -50.60
PAT -50.60
Net Income 0.00
More
Total Assets
Total Assets
Parameter Mar-16 (₹ Cr.) Yoy%change
Total share capital 23.67
Net worth 29.90
Investments 0.00
Total Liability 162.66
Total debt 55.20
Net block 70.83
Total Assets 162.66
Parameter Mar-16 (₹ Cr.) 6M % change
Total share capital 23.67
Net worth 29.90
Investments 0.00
Total Liability 162.66
Total debt 55.21
Net block 70.83
Total Assets 162.66
Company Curr Price Prev. Close Change% W's Low/High

Adani Ports & Special Economic Zone Ltd.

401.2 410.2 -2.19
397.7414.7

Banaras Beads Ltd.

61.1 64.4 -5.12
59.173.8

Binani Industries Ltd.

77.6 81.8 -5.13
75.186.6

Career Point Ltd.

137.55 147.95 -7.03
136.5162.95

Dredging Corporation Of India Ltd.

575.6 599.7 -4.02
572.9621.9

Future Consumer Ltd.

60.85 63.85 -4.7
60.266.35

Gateway Distriparks Ltd.

226.9 230.35 -1.5
222.35240
Company Curr Price Prev. Close Change% W's Low/High

Adani Ports & Special Economic Zone Ltd.

400.9 410.05 -2.23
386.6414.3

Alpha Hi-Tech Fuel Ltd.

0.87 0.91 -4.39
0.870.87

Anil Ltd.

36.3 38.2 -4.97
36.336.3

Bagalkot Udyog Ltd.

23.9 25.15 -4.97
23.923.9

Banaras Beads Ltd.

61.9 64.5 -4.03
60.5571.95

Binani Industries Ltd.

77.35 81.4 -4.98
75.3586.85

Brahmanand Himghar Ltd.

4.08 4.29 -4.9
4.084.08
More
Parameter Mar-16(in ₹ Cr.)
Cash from operating activities 44.21
Cash from investing activities 13.08
Cash from financing activities -50.55
Net change in cash 6.63

Stock Held By Mutual Fund Schemes

Scheme Holding (%)
Axis Long Term Equity Fund 0.26%
UTI Mid Cap Fund 0.79%
UTI Equity Fund 0.45%
UTI Opportunities Fund 0.44%
DSP BlackRock Micro-Cap Fund 0.31%
Axis Focused 25 Fund 0.95%

SAIL eyes higher market share on surging steel demand: Chairman

Armed with latest technologies and higher product mix, SAIL aims to tap big into the steel demand in India, which is projected to become the fifth- largest economy this year, its Chairman P K Singh said. Addressing the 45th annual general meeting of the state- owned Steel Authority of India Ltd (SAIL) here, Singh said the steel demand in India will witness a significant growth in future, given the current stage of development in Indian economy. The World Steel Association, in its short range outlook, has forecast 6.1 per cent growth in steel consumption for India in 2017, the SAIL chief added. According to Singh, the domestic steel demand is improving on the back of government policies and developmental goals, and SAIL is expeditiously equipping itself to serve market requirements fully and claim a broader market share. SAIL with newer and better technologies at its disposal aims to leverage potential of growth in steel demand by operating at rated capacities, product differentiation and customer satisfaction, Singh said. The chairman also shared the company's efforts towards product value addition. SAIL has done significant value addition in its product mix, with higher grades of steel... from Rourkela Steel Plant's new plate mill for the oil and gas sector, SAIL HT-600 for the automotive sector and high strength LPG steel grade from Bokaro Steel Plant, etc, Singh said. At Bhilai Steel Plant (BSP), the world's longest single piece rail of 130 metres is being produced and supplies of welded 260 metres rail panels to the Indian Railways are in progress. Besides, a 3 mtpa hot strip mill in Rourkela is slated to be installed by 2018. He further said, World economic recovery is on track... and presents a healthy sign for industrial and manufacturing activities across globe. India is projected to become the world's fifth-largest economy in 2017, surpassing UK and France and the world's third largest economy by 2023, surpassing Japan and Germany. Such kind of growth will definitely create larger steel demand and boost consumption in country, the chairman added. Listing out the achievements of SAIL, Singh said the company since inception has produced 475 million tonnes (mt) of crude steel and partnered in all major national projects requiring steel. The company is also taking initiatives towards remodelling its operations.

22-09-2017 16:49

PNB plans to raise up to Rs 5000 cr from markets

Punjab National Bank today said it plans to raise up to Rs 5,000 crore equity capital from the markets to fund growth. The public sector bank however did not give any indication as to whether it would be raised by diluting government equity or issuing Additional Tier-1 (AT1) bonds. The decision in this regard would be taken in the board meeting on September 27, PNB said in a filing to the stock exchanges. The bank would consider raising common equity Tier capital up to Rs 5,000 crore as per Basel III requirements, it said. PNB had reported over 12 per cent rise in net profit at Rs 343.40 crore for the quarter ended June 30, 2017. Total income of the bank rose to Rs 14,468.14 crore in the said quarter from Rs 13,475.41 crore a year ago. With regard to assets metrics, the bank's gross non- performing assets (NPAs) declined marginally to 13.66 per cent of gross advances as on June 30, 2017 from 13.75 per cent a year ago. Meanwhile, shares of the Bank closed trading at Rs 137.80 apiece, down 2.92 per cent from the previous close on BSE.

22-09-2017 15:47

SBI's new index at LSE to help investors track Indian bonds

State Bank of India, in partnership with FTSE Russell, brought out a new index series at the London Stock Exchange to enable investors and market participants to track Indian bond movement. FTSE Russell is a global data and analytics provider. The FTSE SBI Bond Index Series demonstrates SBI's commitment to play befitting leadership role in development of India's bond market, State Bank of India (SBI) said in a statement. We have teamed up with FTSE Russell to launch the FTSE- SBI Bond Index Series. This index will act as a key benchmark for Indian debt for foreign investors looking to invest in Indian debt market, SBI Chairman Arundhati Bhattacharya said in the statement. It will significantly contribute to development and broadening of the Indian bond market, Bhattacharya hoped. The index series, SBI said, provides the global investor community and other market participants the tools they need to analyse India's bond market. The launch follows the November 2015 visit of Prime Minister Narendra Modi in the UK when a letter of intent was singed between SBI and FTSE to jointly develop the new index tracking Indian fixed income securities. This initiative was also announced as a priority under the India UK Financial Partnership (IUKFP), SBI said further. Today's launch of this innovative index series demonstrates SBI's commitment to play befitting leadership role in development of India's bond market. This index is also an important enabler of India-focused funds and is expected to facilitate investment flows, the bank said. Meanwhile, shares of the Bank closed trading at Rs 261.90 apiece, down 2.46 per cent from the previous close on BSE.

22-09-2017 15:44

Adhunik Industries hits 52 week low on SAT order

Shares of Adhunik Industries plunged 20 per cent, hitting 52-week low, on the Bombay Stock Exchange after the Securities Appellate Tribunal (SAT) directed the market regulator to reverse their decisions all dated August 7, 2017 qua the appellant forthwith. According to data available with exchange, as much as 792 lakh shares changed hands over-the-counter as compared to two week average of 1.54 lakhs. Weighed down by the development, shares of the company declined as much as 20 per cent to hit 52-week low of Rs 83.55 apiece on the Bombay Stock Exchange. The stocks were currently trading at Rs 83.55 against previous close price of Rs 104.40. In a similar fashion, shares of the company were trading 19.98 per cent lower at Rs 79.10 apiece on the National Stock Exchange. Meanwhile, the broader benchmark BSE Sensex was trading at 31,944.47, down 425.57 points, or 1.30 per cent, at 14:45 hours.

22-09-2017 14:57

Dabur India joins hand with Amazon for ayurveda marketplace

Homegrown FMCG major Dabur India today said it has tied up with e-commerce major Amazon for an online ayurveda marketplace which will house all ayurvedic brands and products available in the country. The company, which will also offer consumers an insight into various ayurvedic medicines for treating a variety of ailments, said the idea is to service all health and personal care related needs of patients. The exclusive ayurveda e-marketplace has been hosted by Amazon India and the content is developed by Dabur India, the company said in a statement. Consumers can search basis companies, brands and ailments and will gain access to all ayurveda solutions available in the country today, Dabur India Executive Director Consumer Care Business KK Chutani said. Products of other ayurvedic manufacturing companies like Baba Ramdev-promoted Patanjali and Himalaya would also feature on the marketplace. By providing A+ content for developing this marketplace, Dabur also gains prime visibility on the portal, Chutani said. Meanwhile, shares of the company were trading at Rs 305.70 apiece, down 1.51 per cent from the previous close at 14:50 hours on BSE.

22-09-2017 14:48

Sun Pharma Advanced - Updates

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding ''Update on Company Information''.

15-Sep-2017 04:01 PM

Sun Pharma Advanced - Press Release / Media Release

Further to out letter No. SPARC/Sec/SE/2017-18/034 dated 10th August 2017 on the subject, please find enclosed a copy of the presentation by the Company providing update on NCE & NDDS programs, which is self-explanatory.

You are requested to kindly take the same on your record & disseminate the information through your website.

24-Aug-2017 01:49 PM

Sun Pharma Advanced - Analysts/Institutional Investor Meet/Con. Call Updates

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates - Further to out letter No. SPARC/Sec/SE/2017-18/034 dated 10th August 2017 on the subject, please find enclosed a copy of the presentation by the Company providing update on NCE & NDDS programs, which is self-explanatory.You are requested to kindly take the same on your record & disseminate the information through your website.

24-Aug-2017 01:47 PM

Sun Pharma Advanced - Analysts/Institutional Investor Meet/Con. Call Updates

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

10-Aug-2017 04:04 PM

Sun Pharma Advanced - Press Release / Media Release

Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we enclose herewith the Press Release on the above mentioned subject being released by the Company, which is self-explanatory.

We request you to kindly take the same on record.

10-Aug-2017 03:59 PM

Sun Pharma Advanced - Press Release / Media Release

Further to out letter No. SPARC/Sec/SE/2017-18/034 dated 10th August 2017 on the subject, please find enclosed a copy of the presentation by the Company providing update on NCE & NDDS programs, which is self-explanatory.

You are requested to kindly take the same on your record & disseminate the information through your website.

24-Aug-2017 01:49 PM

Sun Pharma Advanced - Press Release / Media Release

Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we enclose herewith the Press Release on the above mentioned subject being released by the Company, which is self-explanatory.

We request you to kindly take the same on record.

10-Aug-2017 03:59 PM

Sun Pharma Advanced - Scrutinizer's Report

Pursuant to the requirements of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, we submit herewith the details of the result of remote e-voting as well as e-Poll conducted at the Twelfth Annual General Meeting (AGM) of Sun Pharma Advanced Research Company Limited held on August 5, 2017 from 11:30 a.m. to 12:45 p.m. at Sir Sayajirao Nagargruh, Akota, Vadodara- 390 020, Gujarat in respect of all the resolutions as set out in the Notice dated May 05, 2017 for your information and noting.


All the resolutions contained in the Notice of the above AGM were approved by the requisite majority of Shareholders through remote e-voting and e-poll conducted at the AGM. Copy of Combined Scrutinizers Report is enclosed herewith.

We request you to kindly take note of the same.

07-Aug-2017 02:30 AM

Corporate Details

About Management

2007 - Sun Pharma Advanced Research Co.Ltd was formed in the year 2007, with separation of India's leading specialty pharma company, Sun Pharmaceutical Industries Ltd, and its active projects in drug discovery and innovation into a new company. The parent company, Sun Pharma Industries Ltd continues to invest independently in generic research. - Sun Pharma Advanced Research Company Ltd (SPARCL) had allotted 3,39,441 equity shares of Re 1 each to the bond-holders of Sun Pharma Industries Ltd (SPIL) on conversion of 5,500 foreign currency convertible bonds upon conversion. - Balance Sheet along with the Profit and Loss Account for the year ended March 31, 2007 adopted and the Reports of Directors & Auditors thereon. - Mr. Dilip S Shanghvi and Mr. Sudhir V Valia, re appointed as the Directors of the Company. - According to the clause 10.2 of the scheme of arrangement of demerger, sanctioned by the High Court of Gujarat through its order dated March 01, 2007, issued on March 28, 2007 and as per supplementary Trust Deed dated may 18, 2007, the FCCB's holders of Sun Pharma Industries Ltd, are entitled for one equity share of Re 1 each of the company for every equity share of Rs.5 each of SPIL. 2011 - "Sun Pharma announces USFDA approval for DOCEFREZ (docetaxel) for Injection". 2012 -SPARC - Starhaler Device finalist at Medical Design Excellence Awards -Sun Pharma Advanced Research Company Ltd Issues Rights in the Ratio of 1:7 2013 -SPARC to provide update on NCE & NDDS programs 2014 -SPARC Announces India Approval for Paclitaxel Injection Concentrate for Nanodispersion (PICN)

Registered Office

17-B, Mahal Industrial Estate, Mahakali Caves Road, Andheri (East)

,,,      ,

Registrar Details

Link Intime India Pvt. Ltd.